BR122020025600A2 - uso de 1-[2-(2,4-dimetil-fenilsulfanil)fenil] piperazina e seus sais farmaceuticamente aceitáveis - Google Patents

uso de 1-[2-(2,4-dimetil-fenilsulfanil)fenil] piperazina e seus sais farmaceuticamente aceitáveis

Info

Publication number
BR122020025600A2
BR122020025600A2 BR122020025600A BR122020025600A BR122020025600A2 BR 122020025600 A2 BR122020025600 A2 BR 122020025600A2 BR 122020025600 A BR122020025600 A BR 122020025600A BR 122020025600 A BR122020025600 A BR 122020025600A BR 122020025600 A2 BR122020025600 A2 BR 122020025600A2
Authority
BR
Brazil
Prior art keywords
phenylsulfanyl
piperazine
dimethyl
phenyl
pharmaceutically acceptable
Prior art date
Application number
BR122020025600A
Other languages
English (en)
Portuguese (pt)
Inventor
Ioana Florea
Marianne Dragheim
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44532506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR122020025600(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR122020025600A2 publication Critical patent/BR122020025600A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR122020025600A 2010-08-23 2011-08-22 uso de 1-[2-(2,4-dimetil-fenilsulfanil)fenil] piperazina e seus sais farmaceuticamente aceitáveis BR122020025600A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201000739 2010-08-23
PCT/DK2011/050317 WO2012025123A1 (en) 2010-08-23 2011-08-22 Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine

Publications (1)

Publication Number Publication Date
BR122020025600A2 true BR122020025600A2 (pt) 2021-01-05

Family

ID=44532506

Family Applications (2)

Application Number Title Priority Date Filing Date
BR122020025600A BR122020025600A2 (pt) 2010-08-23 2011-08-22 uso de 1-[2-(2,4-dimetil-fenilsulfanil)fenil] piperazina e seus sais farmaceuticamente aceitáveis
BR112013002194A BR112013002194A2 (pt) 2010-08-23 2011-08-22 uso de 1-[2-(2,4-dimetil-fenilsulfanil)fenil] piperazina e seus sais farmaceuticamente aceitáveis

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112013002194A BR112013002194A2 (pt) 2010-08-23 2011-08-22 uso de 1-[2-(2,4-dimetil-fenilsulfanil)fenil] piperazina e seus sais farmaceuticamente aceitáveis

Country Status (32)

Country Link
US (5) US20130184291A1 (https=)
EP (1) EP2608789B2 (https=)
JP (1) JP5902169B2 (https=)
KR (1) KR101816953B1 (https=)
CN (1) CN103068389A (https=)
AP (1) AP3583A (https=)
AR (1) AR082501A1 (https=)
AU (1) AU2011295465B8 (https=)
BR (2) BR122020025600A2 (https=)
CA (1) CA2807062C (https=)
CL (1) CL2013000492A1 (https=)
CO (1) CO6680652A2 (https=)
CY (1) CY1118886T1 (https=)
DK (1) DK2608789T4 (https=)
ES (1) ES2625142T5 (https=)
FI (1) FI2608789T4 (https=)
HR (1) HRP20170608T4 (https=)
HU (1) HUE034155T2 (https=)
IL (1) IL224371A (https=)
LT (1) LT2608789T (https=)
ME (1) ME02674B (https=)
MX (1) MX349724B (https=)
PL (1) PL2608789T5 (https=)
PT (1) PT2608789T (https=)
RS (1) RS55851B2 (https=)
RU (1) RU2564666C2 (https=)
SG (1) SG187649A1 (https=)
SI (1) SI2608789T2 (https=)
SM (1) SMT201700239T1 (https=)
TW (1) TW201212918A (https=)
WO (1) WO2012025123A1 (https=)
ZA (1) ZA201301385B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106103418A (zh) 2014-01-31 2016-11-09 埃吉斯药物私人有限公司 沃替西汀盐的制备方法
CN104119299B (zh) * 2014-08-13 2016-08-17 北京蓝贝望生物医药科技股份有限公司 沃赛汀或沃替西汀的氢溴酸盐
CN104119298B (zh) * 2014-08-13 2016-08-24 北京蓝贝望生物医药科技股份有限公司 氢溴酸沃赛汀或氢溴酸沃替西汀
CN104610195B (zh) * 2015-01-30 2017-06-27 上虞京新药业有限公司 沃替西汀的天冬氨酸盐或其水合物及其制备方法和用途
WO2018002115A1 (en) 2016-07-01 2018-01-04 H. Lundbeck A/S Vortioxetine dosing regimes for fast onset of antidepressant effect
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DK0543584T3 (da) * 1991-11-18 1996-07-01 Lilly Industries Ltd Benzo(b)thiophen-2-carboxamider til behandling af forstyrrelser i centralnervesystemet
US20080103179A1 (en) * 2006-10-27 2008-05-01 Tam Peter Y Combination Therapy
EP2090769A1 (en) 2000-10-02 2009-08-19 Rohr, Inc. Apparatus, method and system for gas turbine engine noise reduction
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
PL2044043T5 (pl) * 2006-06-16 2022-05-02 H. Lundbeck A/S Bromowodorek 1-[2-(2,4-dimetylofenylosulfanylo)fenylo]piperazyny jako związek o połączonym działaniu wychwytu zwrotnego serotoniny i działaniu na 5-ht3 i 5-ht1a do leczenia upośledzenia funckji poznawczych
TW200848411A (en) 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine
TW200932233A (en) * 2007-11-13 2009-08-01 Lundbeck & Co As H Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity

Also Published As

Publication number Publication date
AR082501A1 (es) 2012-12-12
CO6680652A2 (es) 2013-05-31
HRP20170608T4 (hr) 2024-12-06
WO2012025123A1 (en) 2012-03-01
CA2807062C (en) 2018-07-31
SG187649A1 (en) 2013-03-28
IL224371A (en) 2016-07-31
ME02674B (me) 2017-06-20
US20240293397A1 (en) 2024-09-05
EP2608789A1 (en) 2013-07-03
AU2011295465B2 (en) 2014-06-19
LT2608789T (lt) 2017-05-25
AU2011295465B8 (en) 2014-07-10
EP2608789B2 (en) 2024-08-21
BR112013002194A2 (pt) 2016-05-31
ES2625142T5 (en) 2025-02-10
US20130184291A1 (en) 2013-07-18
HUE034155T2 (en) 2018-01-29
CN103068389A (zh) 2013-04-24
MX349724B (es) 2017-08-10
CA2807062A1 (en) 2012-03-01
PL2608789T5 (pl) 2025-11-12
RS55851B2 (sr) 2024-11-29
JP2013536206A (ja) 2013-09-19
RU2564666C2 (ru) 2015-10-10
SI2608789T2 (sl) 2025-05-30
SI2608789T1 (sl) 2017-06-30
PL2608789T3 (pl) 2017-09-29
AP3583A (en) 2016-02-09
TW201212918A (en) 2012-04-01
ES2625142T3 (es) 2017-07-18
PT2608789T (pt) 2017-05-26
CY1118886T1 (el) 2018-01-10
DK2608789T4 (da) 2024-11-04
JP5902169B2 (ja) 2016-04-13
EP2608789B1 (en) 2017-04-12
HRP20170608T1 (hr) 2017-07-28
AP2013006768A0 (en) 2012-03-31
US20190000836A1 (en) 2019-01-03
DK2608789T3 (en) 2017-05-15
KR101816953B1 (ko) 2018-01-09
US20210085674A1 (en) 2021-03-25
SMT201700239T1 (it) 2017-07-18
RU2013112890A (ru) 2014-09-27
MX2013001570A (es) 2013-03-21
US20220370439A1 (en) 2022-11-24
FI2608789T4 (fi) 2024-11-01
RS55851B1 (sr) 2017-08-31
CL2013000492A1 (es) 2013-06-07
AU2011295465A1 (en) 2013-02-07
KR20130097162A (ko) 2013-09-02
ZA201301385B (en) 2014-04-30

Similar Documents

Publication Publication Date Title
NL301176I2 (nl) Tepotinib en farmaceutisch aanvaardbare solvaten en zouten daarvan
BRPI1015315A2 (pt) composto heterocíclico fundido e uso dos mesmos
DK2421534T3 (da) Flydende formuleringer af salte af 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazin
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
CY1118004T1 (el) Αναστολεις cdk
HRP20190016T1 (hr) Heterociklički spojevi i njihova upotreba
LT3034497T (lt) 3,5-diamino-6-chlor-n-(n-(4-(4-(2-(heksil(2,3,4,5,6-penta-hidroksiheksil)amino)etoksi)fenil)butil)karbamimidoil)pirazin-2-karboksamidas
PT2534153T (pt) Sais e polimorfos de 8-fluoro-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6h-azepino[5,4,3-cd]indol-6-ona
BRPI1009235A (pt) acetamidas substítuidas por 2-(hetero)arila, n-(hetero)arila e seus usos, e composição farmacêutica
HRP20181684T1 (hr) Postupak primjene 4-((1r,3s)-6-klor-3-fenil-indan-1-il)-1,2,2-trimetil-piperazina i njegovih soli u liječenju shizofrenije
CO6930362A2 (es) Compuesto heterocíclico y su uso
HUE043425T2 (hu) Heteroarilpiperidin- és -piperazin-származékok mint fungicidek
DK2398785T3 (da) Oprensning af 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazin
BR112012002349A2 (pt) composto,e, uso do mesmo
NL300998I2 (nl) Lusutrombopag of farmaceutisch aanvaardbare zouten of solvaten daarvan
NL301214I2 (nl) Lasmiditan en farmaceutisch aanvaardbare zouten daarvan
HRP20160726T1 (hr) Soli piperazina i postupak za njihovu pripravu
BRPI0920183A2 (pt) derivados de fenetilamida e seus analogos heterociclicos
BRPI0813263A2 (pt) Oxazolidinonas substituídas e seu uso
SMT201700064B (it) Antagonisti di d2, metodi di sintesi e metodi di uso
IL225785A0 (en) Heterocyclic compounds, compositions comprising the same and uses thereof
BR122020025600A2 (pt) uso de 1-[2-(2,4-dimetil-fenilsulfanil)fenil] piperazina e seus sais farmaceuticamente aceitáveis
BR112012031504A2 (pt) formulações incluindo amiodarona e seus sais e métodos para a sua fabricação e uso
BR112013013551A2 (pt) composto e uso médico do mesmo
BR112013012175A2 (pt) combinação, coadministração, uso e método

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.